What is Morgan Stanley's price target for AFRM?

Morgan Stanley's latest stated price target for Affirm Holdings Inc. (AFRM) is $79, from its action on Jun 25, 2026.

What is Morgan Stanley's rating on AFRM?

Morgan Stanley rates AFRM Equal-Weight, a neutral rating, as of Jun 25, 2026.

When did Morgan Stanley last change its view on AFRM?

On Jun 25, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $79.

Morgan Stanley AFRM price target and rating history

Morgan Stanley rates Affirm Holdings Inc. (AFRM) Equal-Weight with a $79 price target, as of its latest action on Jun 25, 2026. It has published 9 rating actions on AFRM since August 2021, including 2 upgrades and 3 downgrades. Across 12 firms with a AFRM price target in the last 12 months, the median target is $93.50. Morgan Stanley's $79 is 16% below that.

Current rating: Equal-Weight
Price target: $79
Median target, all firms: $93.50
Actions on AFRM: 9

Morgan Stanley price target on AFRM

Morgan Stanley price target on AFRM, each point a stated target, August 2021 to June 2026. Targets before February 2023 (divided by 3) are adjusted for a stock split, going by the prior target Morgan Stanley restated.

Every Morgan Stanley rating on AFRM

Jun 25, 2026
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $79
Feb 3, 2026
UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $76
Oct 9, 2024
UpgradeMorgan Stanley upgrades to Equal-Weight from Underweight, price target $22 to $37
Dec 18, 2023
DowngradeMorgan Stanley downgrades to Underweight from Equal-Weight, price target $15 to $20
Feb 10, 2023
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $46 to $15
Jan 20, 2022
ReiterateMorgan Stanley cuts its price target to $140 from $185, keeps Overweight
Nov 12, 2021
ReiterateMorgan Stanley raises its price target to $185 from $140, keeps Overweight
Sep 10, 2021
ReiterateMorgan Stanley raises its price target to $140 from $120, keeps Overweight
Aug 30, 2021
ReiterateMorgan Stanley raises its price target to $120 from $73, keeps Overweight

How other firms rate AFRM

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Monness, Crespi, Hardt	Buy	$90	Oct 26, 2026
Wolfe Research	Outperform	$90	Sep 14, 2026
Loop Capital	Buy	$105	Sep 9, 2026
Scotiabank	Sector Outperform		Sep 2, 2026
Oppenheimer	Outperform	$104	Aug 28, 2026
Bernstein	Outperform	$100	Jul 22, 2026
Barclays	Overweight	$97	Jul 8, 2026
Piper Sandler	Overweight	$103	Jun 30, 2026
Morgan Stanley	Equal-Weight	$79	Jun 25, 2026
BMO Capital Markets	Outperform	$75	Apr 22, 2026
BofA Securities	Buy	$82	Mar 5, 2026
Robert W. Baird	Neutral	$55	Feb 20, 2026
Needham	Buy	$100	Jan 27, 2026

Questions about Morgan Stanley and AFRM

What is Morgan Stanley's price target for AFRM?: Morgan Stanley's latest stated price target for Affirm Holdings Inc. (AFRM) is $79, from its action on Jun 25, 2026.
What is Morgan Stanley's rating on AFRM?: Morgan Stanley rates AFRM Equal-Weight, a neutral rating, as of Jun 25, 2026.
When did Morgan Stanley last change its view on AFRM?: On Jun 25, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $79.
How does Morgan Stanley's AFRM target compare with other analysts?: Across 12 firms with a AFRM price target in the last 12 months, the median target is $93.50. Morgan Stanley's $79 is 16% below that.

More AFRM rating histories

All Morgan Stanley ratings AFRM news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.